The Registry for Eosinophilic Gastrointestinal Disorders (REGID) is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is a part of the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services, and by the generous donations of families and individuals like you. REGID is a not-for-profit collaboration of medical centers, professionals, families, and individuals dedicated to improving the knowledge, research, and outcomes for people living with eosinophilic gastrointestinal disorders. REGID is not only a national registry of people affected by eosinophilic gastrointestinal disorders but also a forum to enhance the connection of people to resources and research. For more details about the purpose and development of REGID, review the article entitled "National Registry to Track Eosinophilic Disorders".
 

Our Mission

 
The Registry for Eosinophilic Gastrointestinal Disorders (REGID) is a collaboration of medical centers, professionals, families, and individuals whose mission is to improve the knowledge, research, and outcomes for people living with eosinophilic gastrointestinal disorders.
 

REGID Studies

 
REGID studies are designed to expand our knowledge of eosinophilic gastrointestinal disorders and the outcomes of different treatments. To this end, researchers test specific hypotheses and therapies. The REGID studies section is currently under development. Content about the purpose, funding, methods, and results of ongoing and completed REGID studies will be added as the information becomes available.